ERBIN and acute myeloid leukemia: The latest study found that Erbin was the target of miR-183-5p that negatively regulated the Erbin expression, resulting in enhanced cell proliferation of AML cells via activation of RAS/RAF/MEK/ERK and PI3K/AKT/FoxO3a pathways [36].